ArticleCommunications biology2025

A universal monoallelic human leukocyte antigen class II immunopeptidomic platform for defining the immunogenicity potential of therapeutic proteins.

Megan B Lannan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.